Key Financial Performance

  • Q1 FY27 revenue exceeds ₹150 crore, described as "one of the strongest quarterly performances in the Company's history"
  • Management has revised FY27 revenue outlook upward by a minimum of 10%
  • Previous FY27 guidance: ₹600 crore
  • Revised FY27 guidance: ₹660+ crore
  • Management expects profit margins to remain strong, supported by favourable USD-INR realisations and upward pricing trend
  • Management is confident of delivering net profit margins ahead of current guidance

Growth Drivers and Business Updates

  • Expanding opportunities across international B2B healthcare markets from institutional buyers, private sector customers, and government procurement programmes
  • Successful commencement of long-term supply agreement with Partnership for Supply Chain Management (PFSCM), Netherlands
  • Strong order visibility across private markets, institutional business, and international tenders spanning multiple geographies
  • Continued growth in Male Condom (MC) and Female Condom (FC) businesses supported by enhanced manufacturing capabilities and wider market reach
  • Growing opportunities in lubricant portfolio across institutional and consumer channels
  • Significant long-term potential in consumer business building a mainstream personal care and wellness brand
  • Expanding presence across modern trade, organised retail, and pharmacy networks across India
  • Ongoing capacity expansion, operational efficiencies, and backward integration initiatives
  • Active participation in IVD kits and menstrual cup tenders across multiple states
  • Steady progress in In Vitro Diagnostics (IVD) business with potential to become meaningful contributor over coming years

Operational Developments

  • New Palava manufacturing facility expected to be operationalized in the coming quarter
  • Palava facility will amplify production capacity by 1.5 times existing output
  • Annual production capacity augmentation: approximately 770 million male condoms and 75 million female condoms
  • Company exports products to over 125 countries with substantial revenue from international markets
  • Long-term agreements established with WHO/UNFPA & PFSCM

Management Commentary

Mr. Aditya Kumar Halwasiya, Chairman & Managing Director, stated that the strong start reflects the transformation Cupid has undergone over past years, building a diversified business with multiple growth engines. He highlighted strong momentum across international B2B business, encouraging start with PFSCM relationship, and significant strengthening of condom businesses over past twelve months. Management believes the company is entering a new phase of growth with multiple business verticals expected to contribute meaningfully to revenue and profitability.